MedRx Co., Ltd
Notice of Monthly Exercise Status of the 35th Share Acquisition Rights Issued via Third-Party Allotment (Exercise Price Revision Clause)
Monthly exercise status for August 2026 disclosed. Total shares allocated for the target month: 2,323,000 shares; exercised share acquisition rights: 23,230 units; transfer treasury stock fluctuates between 2,264 and 600 shares. Unexercised shares at month-end: 5,616,500 shares; previous month-end: 7,939,500 shares. Exercise restrictions: 3.91%. Monitor future exercise trends and dilution impact.
Key Figures
- Allocated shares: 2,323,000 shares
- Exercised share acquisition rights: 23,230 units
- Unexercised share acquisition rights: 56,165 units (5,616,500 shares)
AI要約
Section Heading
This notice reports the August 2026 monthly exercise status of the 35th share acquisition rights with an exercise price revision clause, allocated to Growth Capital Co., Ltd. The number of allocated shares is 2,323,000, with 23,230 exercised in the month, and the transferred treasury stock ranging daily between 2,264 and 2,049 to 1,000 shares. Unexercised shares at month-end amount to 5,616,500, including 2 treasury shares within the issued share count of 66,207,600. Exercise restrictions under the listing rules stand at 3.91%.
Section 2 Heading
This matter presents insights into dilution impact through the exercise trends of share acquisition rights. Going forward, attention should be paid to monthly exercise status and dilution rate trends. Observing the total issued shares and current unexercised residuals helps assess the shareholder structure and market supply, which can influence investment decisions.
MedRx Co., Ltd
Company overview · Stock price · Financial data · All IR
